Glucotrack (GCTK) Total Liabilities (2010 - 2026)

Glucotrack (GCTK) has reported Total Liabilities for 17 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 2.82% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2026 stood at $3.2 million (down 2.82% YoY), and the FY2025 full-year result was $5.0 million, down 73.54% from the prior year.
• Total Liabilities declined to $3.2 million in Q2 2026 per GCTK's latest filing, from $5.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $18.9 million in Q4 2024 and bottomed at $1.1 million in Q2 2022.
• Historically, Total Liabilities has averaged $3.5 million across 5 years, with a median of $1.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 1008.43% in 2024, then plunged 73.54% in 2025.
• Over 5 years, Total Liabilities stood at $1.2 million in 2022, then soared by 41.39% to $1.7 million in 2023, then jumped by 1008.43% to $18.9 million in 2024, then slumped by 73.54% to $5.0 million in 2025, then plunged by 35.41% to $3.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $3.2 million, $5.0 million, and $5.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.